Most recently, it's been discovered that conolidine and the above mentioned derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in equivalent areas as classical opioid receptors, it binds to a big range of endogenous opioids. Not like most opioid receptors, this receptor acts to be a scavenger and will not activate a next